Updated March 2011
Head, Dept. of Nephrology & Hypertension
Hadassah University Medical Center
Tel: 972-2-6776881
Fax: 972-2-6446335
e-mail: michale@hadassah.org.il
Education
1973-1977: Hadera High School, Hadera, Israel
1980 -1986: School of Medicine, Hebrew University-Hadassah Medical School, Jerusalem, Israel
Academic Degrees
1984 - Degree in Basic Medical Sciences (with honors).
1988 - M.D
1990 - M.Sc. Degree in Neurobiology (with honors).
Specialty boards certification of Israeli Medical Association, Scientific Council
1. Internal Medicine - April 1992
2. Nephrology - December 1994
Awards and Honors:
1982: The Rector’s Award for Excellence, Hebrew University-Hadassah Medical School, Jerusalem
1982, 1983, 1984: The Dean’s Award for Excellence, Hebrew University-Hadassah Medical School, Jerusalem
1992: The Dean’s Award for Excellence in Residency, Hebrew University-Hadassah Medical School, Jerusalem
1993: Israel Society of Internal Medicine Award for best presentation
2004: Outstanding teacher Hebrew University-Hadassah Medical School, Jerusalem
2005: Outstanding teacher Hebrew University-Hadassah Medical School, Jerusalem
2008: The Faculty Price for outstanding teachers
Hospital Appointments
1987: Internship, Hadassah University Hospital, Jerusalem
1988–1991: Resident, Department of Medicine A, Hadassah University Hospital, Jerusalem
1991-1992:Chief Resident, Division of Medicine, Hadassah University Hospital, Jerusalem
1992-1995: Fellow in Nephrology, Nephrology and Hypertension Services, Hadassah University Hospital, Jerusalem
1995-2010: Senior physician, Nephrology and Hypertension Services, Hadassah University Hospital, Jerusalem
2006–2010: In charge of out-patient clinic for follow-up after kidney transplant patients
2010- Head of Nephrology and Hypertension department
University Appointments
1992-1995: Instructor
2007–present: Senior Lecturer
2006–2009: Secretary of the Department ('Chug') of Internal Medicine of the Hebrew University
2006–present: Member, the committee for student exchange program of the Medical School
National Appointments
2006- 2010: Member of the Nephrology Advisory Committee to the National Committee for Organ Transplantation
2007–Present: Head of the Israeli Nephrology and Hypertension Board Committee
2010: Head of Nephrology and Hypertension department Hadassah Medical Center
Research Experience
1987–1990: M.Sc. Thesis entitled: The influence of quinine on the neuromuscular junction in a frog. Under the supervision of Prof. Rami Rachamimof. Department of Neurobiology, Hadassah Medical School, Hebrew University, Jerusalem.
1994–1995: The effect of PTH on calcium metabolism in neonatal rat calvaria - intracellular signals. (#2)
1994–1998: The effect of vitamin D derivatives on calcium metabolism in neonatal rat calvaria - intracellular signals. (#4, #7)
1996–2000:Regulation of PTH receptor mRNA in acute renal failure and chronic renal failure: Effect of vitamin D derivatives. (#8)
1997-2000:Regulation of PTH receptor mRNA in Opposum kidney cells - Effect of vitamin D derivatives. (#3)
1998–2000: Regulation of NaPi-2 mRNA and protein in chronic renal failure. Effect of PTH and dietary phosphate. (#12, #13)
2000-2001: Post-doctorate at the University of Pennsylvania, Dept. of Pathology and Laboratory Medicine (head Prof. M.L. Tykocinski). Project: Immunomodulatory fusion proteins - trans-signal converting proteins. (#11)
2001-present: Production, applications and mechanism of action of immunomodulatory fusion proteins CTLA- 7- and CD40 FasL (15-18)
2008–present: The use of Fn14-Trail as anti-cancerous and an immunomodulatory treatment in in-vitro and in-vivo models.
Clinical Research
1993-present: Chronic ambulatory peritoneal dialysis as treatment for NYHA-IV congestive heart failure. (#6)
2003-2005: Human erythropoietin gene therapy for patients with chronic renal failure (clinical study) (Co - PI) (#14)
2005-2007: The effect of Suledoxide on microproteinuria of diabetic patients (clinical study) (PI)
2008–present: Pregnancies among kidney transplant patients (PI)
Teaching Assignments
1988-2000: Physical diagnosis for medical students [4th (course No 96713) and 6th years]
1988–present: Internal Medicine for medical students (4th and 6th years)
1998-2002: Renal pathophysiology in physiology course for 2nd year medical students Course no 75206.
1993–present: Introductory course in internal medicine to 4th year medical students - nephrology. Course No 96713
Nephrology for 6th year medical students.
Nephrology in intensive care, student nurses.
1996-1999: Course of disease to 1st and 2nd degree pharmacology students. Course No 64720
2002-2008: In charge of nephrology teaching program of medical students.
National Examinations
2003: Examining in the final board examinations in Internal Medicine
2004–2007: Member of the committee writing the National Final Exams in Internal Medicine for medical students.
2003-2007: Member of the committee writing the National Board Examinations in Nephrology.
2005–2007: Examining in the final board examinations in Nephrology.
2007-present: Head of the committee of the National Board Examinations in Nephrology.
Invited Lectures
2002 – The annual Research day of the Israel Society of nephrology entitled – "CTLA-4·FasL induces alloantigen-specific hyporesponsiveness." Invited lecture
2006 – The research forum of the Nephrology Services in Rambam Medical Center entitled "Immunomodulatory fusion proteins." Invited lecture
2007 – The annual joint meeting of the Israeli Society of Nephrology and The Israeli Society of Transplantation entitled "Living donors Follow-Up" Invited lecture
2008 – The meeting of the Jerusalem Nephorology Forum – entitled " Current protocols in immunosupressio for kidney transplantation" Invited lecture
2008 – Symposium on Glomerular Disease of the Israel Society of Nephrology, entitled "Kidney transplantation for FSGS" Invited lecture
2009 - The annual Meeting of the Israeli Society of Nephrology and Hypertension – The annual journal club Invited lecture
2009 - The Annual Meeting of the Israeli Society of Gene Therapy- An autologus transduced biopump with an adenogutless EPO vector for the therapy of anemia in chronic renal failure patients
2010 – The Board Review Course of the Israeli Socierty of Nephrology and Hypertension - Immunobiology of Transplantation. Invited lecture
Organizing Scientific Meetings
2009: Transplantation Immunology - 2 meetings organized for theIsraeli Society of Nephrology and Hypertension and the Israely Society of Transplantation (joint meetings)
2010: In charge of the Transplantation Section sScientific Progrnam for the National Board Review Program
LIST OF PUBLICATIONS
Original
1. Ilan YPI, M Dranitzki-ElhalelC, D RubingerC, J Silverc, MM PopovtzerC. 1994. Erythrocytosis after renal transplantation. The response to theophylline treatment. Transplantation 17: 661-664, 3.568; 3/19; 20 (Transplantation). Original.
2. Sprague SMPI, MM PopovtzerC, M Dranitzki-ElhalelC, H WaldC. 1996. Parathyroid hormone-induced calcium efflux from cultured bone is mediated by protein kinase C translocation. Am J Physiol 271: F1139-F1146, 4.345; 3/52 ; 4 (urology and Nephrology). Original.
3. Wald HC, M Dranitzki-ElhalelC, R BackenrothC MM PopovtzerPI. 1998 .Evidence for interference of vitamin D with PTH/PTHrP receptor expression in opossum kidney cells. Eur J Physiol (Pflügers Arch) 436: 289-294, 2.26; 29/74; 2 (Physiology) Original
4. Dranitzki-Elhalel MPI, H WaldC, S SpragueC, MM PopovtzerPI. 1998. The effect of 24,25 dihydroxyvitamin D3 on calcium efflux - the role of protein kinase C. Nephrology 4: 157-162, 0.278; 48/52; 2 (urology and Nephrology). Original
5. Nisman BPI, J LafairC, O LyassC, M Dranitzki-ElhalelC, V BarakPI. 1998 Serum levels of CEA, SCC, TPS and CYFRA 21-1 in hemodialysis patients. J Tumor Marker Oncol 13: 87-93,. 0.163 (oncology) Original
6. Dranitzki-Elhalel MPI, D RubingerC, A MoscoviciC, Y HavivC, M FriedlaenderC, J SilverC, MM PopovtzerC 1998. CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transpl 13: 3041-3042; 14,. 2.840; 9/52; (urology and Nephrology). Original.
7. Dranitzki-Elhalel MPI, H WaldC, MM PopovtzerC, SM SpraguePI. 1999. 1,25-dihydroxyvitamin D3-induced calcium efflux from calvaria is mediated by protein kinase C. J Bone Miner Res 14: 1822-1827, 5.436; 13/87; 3 (Endocrinology and Metabolism). Original.
8. Friedlaender MMPI, H WaldC, M Dranitzki-ElhalelC, HK ZajicekC, M LeviC, MM PopovtzerC. 2001. Vitamin D reduces renal NaPi-2 in PTH-infused rats: complexity of vitamin D action on renal Pi handling. Am J Physiol 281: F428-F433, 4.345; 3/52; 4 (Urology and Nephrology).Original.
9. HavivPI YS, H WaldC, M LeviC, M Dranitzki-ElhalelC, MM PopovtzerPI. 2001. Late-onset downregulation of NaPi-2 in experimental Fanconi syndrome. Pediatr Nephrol 16: 412-416, 1.440; 24/52;1 (Urology and Nephrology).Original.
10. Gal-MoscoviciPI A, D RubingerC, R WeissC, M Dranitzki-ElhalelC,PopovtzerPIMM. 2002. Stimulation of osteoclastic bone resorption in acute renal failure: Evidence for parathyroid hormone-independent mechanism. Bone 31: 488-491, 3.350; 23/87 (Endocrinology and Metabolism). Original.
11. Dranitzki-Elhalel MPI, JH HuangC, W SchmidtC, Y RachmilevichC, ML TykocinskiPI 2003. CTLA-4-FasL induces alloantigen-specific hyporesponsiveness. J Immunol. Jun 15;170(12):5842-50. 6.486; 11/111;7 (Immunology). Original.
12. Dranitzki- Elhalel MPI, H WaldC, D RubingerC, A Gal-MoscoviciC, M LeviC, MM PopovtzerPI. 2004. Regulation of NaPi-2 mRNA and transporter protein in chronic renal failure: Role of parathyroid hormone (PTH) and dietary phosphate (Pi). Eur J Physiol (Pflügers Arch) Dec;449(3):265-70. 2.26; 29/74; 3 (Physiology). Original
13. Freidlaender MMPI, Wald HC, Dranitzki Elhalel MC, Levi MC, Popovtzer MMC. 2004. Recovery of renal tubule phosphate reabsorption despite reduced levels of sodium-phosphate transporter. Eur J Endocrinol. Dec;151(6)797-801. 3.140; 29/74; 1. (Endocrinology and Metabolism). Original.
14. Lippin YPI, Dranitzki-ElhalelPI M, Brill-Almon EC, Mei-Zahav CC, Mizrachi SC, Liberman YC, Iaina AC, Kaplan EC, Podjarny EC, Zeira EC, Harati MC, Casadevall NC, Shani NC, Galun EPI. 2005. Human erythropoietin gene therapy for patients with chronic renal failure. Blood. Oct 1;106(7):2280-6. 9.782; 3/62; 17. (Hematology). Original. Multi-Center study
15. Dranitzki-Elhalel, MPI, Huang, J-HC, Rachmilewitz, JC, Pappo OC, Parnas, MT, Schmidt, WC, and ML TykocinskiC 2006 CTLA-4·FasL Inhibits Allogeneic Responses In Vivo. Cellular Immunology 239(2):129-351.988; 61/111; 2(Immunology). Original.
16. Dranitzki-Elhalel MPI, Huang JHC, Sasson MC, Rachmilewitz JC, Parnas MT and ML TykocinskiPI 2007 CD40·FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism. International immunology, Apr 19(4) 355-63. 3.317 34/111; 1 (Immunology). Original.
17. Ariel OrbachC, Rachmilewitz JC, Huang JHC, Parnas MT, Tykocinski MLC and Dranitzki Elhalel MPI CTLA-4·FasL induced early apoptosis by interfering with anti-apoptotic signals. 2007 J Immunol. Dec 1;179(11):7287-94 6.486; 11/111;2 (Immunology). Original.
Case reports
1. Almog YPI, M DranitzkiC, E LaxC, Y ZimmermanC, B GlazerC. 1992. Sigmoid volvulus presenting as a secretory diarrhea responsive to actreotide. Am J Gastroenterol 87: 148-154, 4.716;5/46 (Gastroenterology and Hepatology). Case report.
2. Almog YPI, G PolliackC, M Dranitzki-ElhalelC, M ShalitC, E, RosenmannC. 1993. Bilateral pulmonary artery aneurysms in Behcets disease. Eurp Respir J6: 1067-1069, 3.096;8/33;13 (Respiratory System). Case report.
3. R SafadiPI, M Dranitzki-ElhalelC, M PopovtzerC, A Ben-Yehudac. 1996. Metformin-induced lactic acidosis associated with acute renal failure. Am J Nephrol 16: 520-522, 1.342;26/52; 13 (Urology and Nephrology). Case report.
4. Friedlaender MMPI, E RosenmannC, D RubingerC, J SilverC, A MoscoviciC, M Dranitzki-ElhalelC, MM PopovtzerC, Y BerlatzkyC, A EidC. 1996. Successful renal transplantation from two cases of methanol intoxication. Transplantation 61: 1549-1552, 3.568; 3/19 (Transplantation). Case report
5. Oppenheim API, R PizovC, M Elhalel-DranitzkiC, YS HavivC. Intravenous dopamine associated with nephrogenic diabetes insipidus-like syndrome. Clin Drug Invest 17: 167-169, 1999. 0.770; 154/187 (Pharmacology and Pharmacy). Case report.
6. Haviv YSPI, M Dranitzki-ElhalelC, M FriedlaenderPI 1999. Chronic inflammatory demyelinating polyneuropathy possibly associated with tacrolimus. Clin Drug Invest 18: 169:172, 0.770; 154/187 (Pharmacology and Pharmacy). Case report.
7. Haviv YSPI, I GotsmanC, M Dranitzki-ElhalelC. 2000. Beta-interferon induced nephrotic syndrome in a patient with multiple sclerosis. Letter to the Editor. Clin Nephrol 54: 425-426, 1.316; 28/52, (Urology and Nephrology). Case report.
Reviews
1. Safadi RPI, Y AlmogC, M Dranitzki-ElhalelC, E RosenmannC, R TurKaspaC. 1996. Glomerulonephritis associated with acute hepatitis B. Am J Gastroenterol 91: 138-139, Review, 4.716;5/46; 1 (Gastroenterology and Hepatology).
2. MM PopovtzerPI, A MoscoviciC, M Dranitzki-ElhalelC, H WaldC, MM FriedlaenderC, D RubingerC. 1996. 24,25(OH)2 vitamin D3 - a controversial metabolite of vitamin D3. Portu Nephrol and Hypert 10(Suppl 10): S119-S127, Review.
3. Silver JPI, Dranitzki-Elhalel MC. 2003. Sensing phosphate across the kingdoms. Curr Opin Nephrol Hypertens. Jul;12(4):357-61. 2.840; 9/52; 1 (Urology and Nephrology).Review.
Chapters in Books
1. Mark L. Tykocinski, Jui-Han Huang, Matthew C. Weber, and Michal Dranitzki-Elhalel, 2008, A Tapestry of Immunotherapeutic Fusion Proteins: From Signal Conversion to Auto-stimulation. In the NIH Book series of Infectious disease, book - National Institute of Allergy and Infectious Diseases, part IV, subpart 5, pages 349-356.
Presentations at Meetings
1. Sprague SM, H Wald, M Dranitzki-Elhalel , MM Popovtzer. Protein kinase C, but not cyclic AMP, mediates parathyroid hormone induced calcium efflux from cultured bone. Annual Meeting of the Israel Society of Nephrology and Hypertension, Herzliya 1994. (Poster)
2. Sprague S, H Wald, M Dranitzki-Elhalel , M Popovtzer. Parathyroid hormone induced calcium efflux from cultured calvaria is protein kinase C dependent. 27th Annual Meeting of the American Society of Nephrology, Orlando 1994. (Poster)
3. Wald H, S Sprague, M Dranitzki-Elhalel , MM Popovtzer. 1,25(OH)2D3 induced efflux of calcium from cultured calvaria is mediated by activation of protein kinase C. 27th Annual Meeting of the American Society of Nephrology, Orlando 1994. (Poster)
4. Dranitzki-Elhalel M, H Wald, S Sprague, MM Popovtzer. Opposite effects of 1,25(OH) 2D3 on calcium efflux from cultured bone: evidence for protein kinase C (PKC)-related mechanism of action. 28th Annual Meeting of the American Society of Nephrology San Diego 1995. (Oral presentation)
5. Dranitzki-Elhalel M, H Wald, S Sprague, MM Popovtzer. The effect of 1,25(OH) 2D3 on calcium efflux from cultured calvaria is mediated by activation of protein kinase C. Annual Meeting of the Israel Society of Nephrology and Hypertension, Zihron Yaacov 1995. (Poster)
6. Popovtzer MM, R Backenroth-Maayan, M Dranitzki-Elhalel, D Rubinger, MM Friedlaender, J Silver, A Moscovici..Recurrence of tumoral calcinosis after kidney transplantation: Evidence against an intrinsic defect of tubular phosphate (Pi) reabsorption. 28th Annual Meeting of the American Society of Nephrology, San Diego 1995. (Poster)
7. Dranitzki-Elhalel M, D Rubinger, A Moscovici, R Backenroth, Y Haviv, M Friedlaender, J Silver, MM Popovtzer. Improved functional capacity in patients with intractable cardiac insufficiency (CHF) with CAPD therapy. 29th Annual Meeting of the American Society of Nephrology, New Orleans 1996. (Poster)
8. Dranitzki-Elhalel M, H Wald, S Sprague, M Popovtzer. Opposite effect of vitamin D derivatives on calcium efflux from cultured bone: The role of protein kinase C. Annual Meeting of the Israel Society of Nephrology and Hypertension, Herzliya 1996. (Poster)
9. Rubinger D, H Wald, M Elhalel, H Garty, MM Popovtzer. The effect of reduction of renal mass on the regulation of CHIF in colon and kidney medulla. 6th International Congress of Nephrology, Madrid, 1997. (Poster)
10. Rubinger D, M Elhalel-Dranitzki, H Wald, H Garty, MM Popovtzer. The effect of chronic renal insufficiency (CRI) on CHIF mRNA in colon and renal medulla. 30th Annual Meeting of the American Society of Nephrology, San Antonio, 1997. (Poster)
11. Wald H, M Elhalel-Dranitzki, R Backenroth, MM Popovtzer. Modulation of PTH action on kidney by 1,25(OH) 2vit D3: Evidence for downregulation of PTH/PTHrP receptor mRNA by vit D. 30th Annual Meeting of the American Society of Nephrology, San Antonio, 1997. (Oral presentation)
12. Backenroth A, D Rubinger, J Silver, MM Friedlaender, M Elhalel-Dranitzki, A Moscovici, E Galun, R Barsuk, MM Popovtzer. Coinfection with hepatitis B (HBV) and hepatitis C (HCV) virus in kidney transplant patients (KTx). 30th Annual Meeting of the American Society of Nephrology, San Antonio, 1997. (Poster)
13. Backenroth R, M Elhalel-Dranitzki, SM Sprague, H Wald, GV Segre, MM Popovtzer. Strain of opossuum kidney cells with spontaneously elevated basal cAMP levels: Evidence for decreased PTH/PTHrP receptor RNA expression and a key role of cAMP in modulating Na-coupled phosphate uptake. 30th Annual Meeting of the American Society of Nephrology, San Antonio, 1997. (Poster)
14. Elhalel-Dranitzki M, H Wald, D Rubinger, MM Popovtzer. 1,25(OH) 2D3 (1,25) upregulates PTH/PTHrP receptor (PRH-R) mRNA in rats with chronic renal failure (CRF). 30th Annual Meeting of the American Society of Nephrology, San Antonio, 1997. (Poster)
15. Backenroth R, C Block, R Yisraeli, Revis, M Elhalel-Dranitzki, A Moscovici, M Friedlaender, M Shapira, D Rubinger, MM Popovtzer. Outbreak of blood stream infections in a hemodialysis unit related to use of a dialysis machine waste port. 31st Annual Meeting of the American Society of Nephrology, Philadelphia, 1998. (Poster)
16. Elhalel-Dranitzki M, D Rubinger, A Moscovici, H Wald, V Sorribas, M Levi, MM Popovtzer. Reduced NaPi-2 gene expression I chronic renal failure (CRF): underlying mechanism of tubular phosphaturic adaptation. . 31st Annual Meeting of the American Society of Nephrology, Philadelphia, 1998. (Poster)
17. Haviv YS, MM Friedlaender, M Elhalel-Dranitzki, A Vaknin, N Levin, MM Popovtzer. Association of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with tacrolimus administration. XVth International Congress of Nephrology, Sydney, 1999. (Poster)
18. Moscovici A, MM Friedlaender, D Rubinger, M Elhalel-Dranitzki, YS Haviv, R Mizrahi, MM Popovtzer. Pseudomonas infection outcome in patients treated by peritoneal dialysis. XVth International Congress of Nephrology, Sydney, 1999. (Poster)
19. Elhalel-Dranitzki M, D Rubinger, A Moscovici, H Wald, M Levi, MM Popovtzer. Reduced NaPi-2 gene expression in chronic renal failure: underlying mechanism of tubular phosphaturic adaptation. XVth International Congress of Nephrology, Sydney, 1999. (Poster)
20. Friedlaender MM, R Backenroth, D Rubinger, M Elhalel-Dranitzki, A Moscovici, MM Popovtzer. Kidney transplantation in patients with familial mediterranean fever (FMF). XVth International Congress of Nephrology, Sydney, 1999. (Poster)
21. Rubinger D, D Gimelreich, MM Friedlaender, M Elhalel-Dranitzki, H Wald, M Levi, MM Popovtzer. Renal phosphate transport during ischemic reperfusion injury (IRI) in the kidney. 32nd Annual Meeting of the American Society of Nephrology, Miami, 1999. (Poster)
22. Elhalel-Dranitzki M, D Rubinger, A Moscovici, H Wald, M Levi, MM Popovtzer. Reduced NaPi-2 gene expression in chronic renal failure: role of parathyroid hormone (PTH) and dietary phosphate (Pi). 32nd Annual Meeting of the American Society of Nephrology, Miami, 1999. (Poster)
23. Friedlaender MM, H Wald, M Elhalel-Dranitzki, M Levi, MM Popovtzer. Chronic administration of 1,25(OH) 2D3 decreases renal NaPi2 mRNA expression in PTH-infused PTX rats. 32nd Annual Meeting of the American Society of Nephrology, Miami, 1999. (Poster)
24. Elhalel-Dranitzki M, H Wald, D Rubiner, A Gal-Moscovici, M Levi, MM Popovtzer. Regulation of NaPi-2 mRNA and transporter protein in chronic renal failure: Role of parathyroid hormone (PTH and dietary phosphate (Pi). 33rd Annual Meeting of the American Society of Nephrology, Toronto, 2000. (Poster)
25. Haviv YS, H Wald, M Levi, M Dranitzki-Elhalel, MM Popovtzer. Late-onset down-regulation of NaPi- 2 in experimental Fanconi's syndrome. 33rd Annual Meeting of the American Society of Nephrology, Toronto, 2000. (Poster)
26. Gal-Moscovici A, D Rubinger, R Arbel, M Elhael-Dranitzki, MM Popovtzer. Contrasting effect of vitamin D derivatives on bone metabolism in rats with glycerol-induced acute renal failure (ARF). 33rd Annual Meeting of the American Society of Nephrology, Toronto, 2000. (Poster)
27. Dranitzki-Elhalel M, JH Huang, W Schmidt, ML Tykocinski. CTLA-4·FasL induces alloantigen-specific hyporesponsiveness. 34th Annual Meeting of the American Society of Nephrology, Philadelphia, 2002. (Poster)
28. Dranitzki-Elhalel M, JH Huang, W Schmidt, ML Tykocinski. CTLA-4·FasL induces alloantigen-specific hyporesponsiveness. The Israel Society of Nephrology and Hypertension. Research Meeting, Jerusalem 2002. (Invited Lecture).
29. Dranitzki-Elhalel M, JH Huang, M Parnas, J Rachmilewitch, W Schmidt, ML Tykocinski CTLA-4·FasL induces inhibition of alloresponse in-vivo, Annual Meeting of the Israel Society of Nephrology and Hypertension, Eilat, 2003. Oral presentation.
30. Dranitzki-Elhalel M, JH Huang, M Parnas, J Rachmilewitch, W Schmidt, ML Tykocinski CD40·FasL inhibits human T cells proliferation (Poster).
31. Dranitzki-Elhalel M, JH Huang, M Parnas, J Rachmilewitch, W Schmidt, ML Tykocinski CTLA-4·FasL induces inhibition of alloresponse in-vivo 37th Annual Meeting of the American Society of Nephrology, Philadelphia, 2005. (Poster).
32. M Sasson, JH Huang, M Parnas, J Rachmilewitch, W Schmidt, ML Tykocinski Dranitzki-Elhalel M CD40·FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism 37th Annual Meeting of the American Society of Nephrology, Philadelphia, 2005. (Poster)
33. Ariel Orbach, Rachmilewitz J, Huang JH, Parnas M, Tykocinski ML and Dranitzki Elhalel M The annual Meeting of the Israel Society of Nephrology and Hypertension, Eilat. "CTLA-4·FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals". 2007. Oral Presentation.
34. Ariel Orbach, Rachmilewitz J, Huang JH, Parnas M, Tykocinski ML and Dranitzki Elhalel M The annual meeting of the American Society of Immunolgy – Seattle 2009 "CD40×FasL and CTLA-4×FasL fusion proteins induce apoptosis in malignant cell lines by dual signaling" Poster
35. Dranitzki Elhalel M, Tur-Sinay M, Hodaya B, Salnikova A, Prigozina T, Shani N, Tykocinski ML, and Talma Brenner. The 9th International Conference on New Trends In Immunosuppression and Immunotherapy 2010 Geneva – "Fn14-Trail, a novel fusion protein, and effective treatment of inflammatory diseases" – Oral Presentation